We serve Chemical Name:4-(4-bromophenyl)benzenesulfonic acid CAS:78079-08-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:4-(4-bromophenyl)benzenesulfonic acid
CAS.NO:78079-08-0
Synonyms:4′-bromobiphenyl-4-sulfonic acid;4-benzenesulfonyloxy-4′-bromobiphenyl;4′-bromo-4-biphenylylsulphonic acid;4-BROMO-4′-SULFOBIPHENYL
Molecular Formula:C12H9BrO3S
Molecular Weight:313.16700
HS Code:2904909090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:62.75000
Exact Mass:311.94600
LogP:4.44360
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 4′-bromobiphenyl-4-sulfonic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-BROMO-4′-SULFOBIPHENYL physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4′-bromo-4-biphenylylsulphonic acid Use and application,4′-bromo-4-biphenylylsulphonic acid technical grade,usp/ep/jp grade.
Related News: A nasal therapy, built upon on the application of a new engineered IgM antibody therapy for COVID-19, was more effective than commonly used IgG antibodies at neutralizing the COVID-19 virus in animal models, according to research recently published by The University of Texas Health Science Center at Houston (UTHealth), The University of Texas Medical Branch at Galveston (UTMB Health), the University of Houston, and IGM Biosciences, Inc. (E)-but-2-en-1-ylarsane manufacturers Mindset is developing several novel families of next generation psychedelic compounds, as well as an innovative process to chemically synthesize psilocybin as well as its own proprietary compounds. 4-methoxy-7,7-dimethyl-6-phenyl-7H-pyrimido[4,5-b][1,4]thiazine suppliers Another area AZ sees as a growth opportunity in China is rare diseases. In announcing its recent $39 billion acquisition of Alexion late last year, Soriot highlighted the potential to expand the Boston firm’s rare disease portfolio to China. (2S,4R)-4-(tert-butyldimethylsilanyloxy)-2-(4-methanesulfonylaminomethylthiazol-2-yl)-1-(p-nitrobenzyloxycarbonyl)pyrrolidine vendor & factory.
